PTPRC and metastatic malignant neoplasm in the lymph nodes: The possibility of using the serum level of ABPs, the number of CD45+ leukocytes and CD326+ CTCs containing these ABPs to predict lymph node metastasis in patients with HNSCC was evaluated by the ROC analysis.